Denali Therapeutics Inc header image

Denali Therapeutics Inc

DNLI

Equity

ISIN US24823R1059 / Valor 39149539

NASDAQ (2024-11-20)

USD 24.42+0.33%

Denali Therapeutics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases. Leveraging their expertise in the biology of these conditions, the company's core portfolio includes programs in various stages of clinical and preclinical development aimed at addressing the underlying causes of these diseases. With a commitment to rigorous therapeutic discovery and development, Denali is dedicated to advancing molecular therapeutics that have the potential to significantly improve the lives of patients facing these challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

27.3%1Y

-48.2%3Y

46.7%5Y

Performance

65.4%1Y

63.4%3Y

67.5%5Y

Volatility

3503 M

Market cap (USD)

273,602

Daily traded volume (Shares)

24.83 / 23.83

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

The Platform Group AG

The Platform Group AG Valor: 57796644

Annual Return

-50%0%+50%

Risk level

110

4.21%EUR 7.42

Cencora Inc

Cencora Inc Valor: 1212868

Annual Return

-50%0%+50%

Risk level

110

0.92%USD 243.20

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

0.64%SEK 298.00

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Valor: 2676862

Annual Return

-50%0%+50%

Risk level

110

-4.04%SEK 289.80

Essity AB

Essity AB Valor: 36846754

Annual Return

-50%0%+50%

Risk level

110

0.51%SEK 297.00

Camurus AB

Camurus AB Valor: 30510553

Annual Return

-50%0%+50%

Risk level

110

1.01%SEK 550.00

Medicover AB

Medicover AB Valor: 36765439

Annual Return

-50%0%+50%

Risk level

110

-0.12%SEK 173.40

Arjo AB

Arjo AB Valor: 39115843

Annual Return

-50%0%+50%

Risk level

110

-1.73%SEK 33.02

Xvivo Perfusion AB

Xvivo Perfusion AB Valor: 19661174

Annual Return

-50%0%+50%

Risk level

110

-1.11%SEK 447.00

Oncopeptides AB

Oncopeptides AB Valor: 35671972

Annual Return

-50%0%+50%

Risk level

110

3.48%SEK 1.49

SIX

FactSet

Clearbit

Logos provided by Clearbit